Long-term survival in patients with metastatic melanoma who received ipilimumab in four phase II trials

被引：0
|
作者：
Lebbe, Celeste
Weber, Jeffrey S.
Maio, Michele
Neyns, Bart
Harmankaya, Kaan
Hamid, Omid
O'Day, Steven
Chin, Kevin M.
McDowell, Diane Opatt
Cykowski, Lori
McHenry, Brent
Wolchok, Jedd D.
机构：
[1] Hop St Louis, Paris, France
[2] Comprehens Melanoma Res Ctr, Moffitt Canc Ctr, Tampa, FL USA
[3] Univ Hosp Siena, Ist Toscano Tumori, Siena, Italy
[4] UZ Brussel, Brussels, Belgium
[5] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, Vienna, Austria
[6] Angeles Clin & Res Inst, Santa Monica, CA USA
[7] Beverly Hills Canc Ctr, Beverly Hills, CA USA
[8] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[9] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9053
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Serum protein predictors of long term survival from combined ipilimumab and nivolumab therapy in metastatic melanoma patients
    Homicsko, Krisztian
    Cuendet, Michel A.
    Michielin, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Long-term results with nivolumab and ipilimumab in melanoma
    Giacco, Vincenzo
    NATURE CANCER, 2025, 6 (03) : 407 - 407
  • [43] UPDATED SURVIVAL OF PATIENTS WITH PREVIOUSLY TREATED METASTATIC UVEAL MELANOMA WHO RECEIVED TEBENTAFUSP
    Sacco, Joseph
    Carvajal, Richard
    Butler, Marcus
    Shoushtari, Alexander
    Hassel, Jessica
    Ikeguchi, Alexandra
    Hernandez-Aya, Leonel
    Nathan, Paul
    Hamid, Omid
    Piulats, Josep
    Rioth, Matthew
    Johnson, Douglas
    Luke, Jason
    Espinosa, Enrique
    Leyvraz, Serge
    Holland, Chris
    McCully, Michelle
    Abdullah, Shaad
    Sato, Takami
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A568 - A568
  • [44] Long-Term Survival in Patients With Advanced Melanoma
    van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Jalving, Hilde
    Bloem, Manja
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot J. W. B., Jan Willem
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Leeneman, Brenda
    Piersma, D.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil G., Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [45] Gauging the Long-Term Benefits of Ipilimumab in Melanoma
    Ribas, Antoni
    Flaherty, Keith T.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1865 - U11
  • [46] Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial
    Kluger, Harriet M.
    Chiang, Veronica
    Mahajan, Amit
    Zito, Christopher R.
    Sznol, Mario
    Thuy Tran
    Weiss, Sarah A.
    Cohen, Justine, V
    Yu, James
    Hegde, Upendra
    Perrotti, Elizabeth
    Anderson, Gail
    Ralabate, Amanda
    Kluger, Yuval
    Wei, Wei
    Goldberg, Sarah B.
    Jilaveanu, Lucia B.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (01) : 52 - +
  • [47] Long-term survivors in phase I clinical trials: Who are they and what predicts their survival?
    Rodriguez, Begona Jimenez
    Michie, Caroline Ogilvie
    Lorente, David
    Hassam, Hasina
    Toloui, Helen Nicole
    Lovosgaldeano, Jimena
    Goswami, Debarati
    De Bono, Johann Sebastian
    Kaye, Stan B.
    Banerji, Udai
    Molife, L. Rhoda
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Clinical determinants of long-term survival in metastatic uveal melanoma
    Koch, Elias A. T.
    Petzold, Anne
    Wessely, Anja
    Dippel, Edgar
    Erdmann, Michael
    Heinzerling, Lucie
    Hohberger, Bettina
    Knorr, Harald
    Leiter, Ulrike
    Meier, Friedegund
    Mohr, Peter
    Rahimi, Farnaz
    Schell, Beatrice
    Schlaak, Max
    Terheyden, Patrick
    Schuler-Thurner, Beatrice
    Ugurel, Selma
    Utikal, Jochen
    Vera, Julio
    Weichenthal, Michael
    Ziller, Fabian
    Berking, Carola
    Heppt, Markus, V
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1467 - 1477
  • [49] Clinical determinants of long-term survival in metastatic uveal melanoma
    Elias A. T. Koch
    Anne Petzold
    Anja Wessely
    Edgar Dippel
    Michael Erdmann
    Lucie Heinzerling
    Bettina Hohberger
    Harald Knorr
    Ulrike Leiter
    Friedegund Meier
    Peter Mohr
    Farnaz Rahimi
    Beatrice Schell
    Max Schlaak
    Patrick Terheyden
    Beatrice Schuler-Thurner
    Selma Ugurel
    Jochen Utikal
    Julio Vera
    Michael Weichenthal
    Fabian Ziller
    Carola Berking
    Markus V. Heppt
    Cancer Immunology, Immunotherapy, 2022, 71 : 1467 - 1477
  • [50] Ipilimumab Ups Survival in Metastatic Melanoma Phase III Trial
    不详
    ONCOLOGY-NEW YORK, 2010, 24 (07): : 648 - 648
12345